Cargando…
Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer
The recognition that colorectal cancer (CRC) is a heterogeneous disease in terms of clinical behaviour and response to therapy translates into an urgent need for robust molecular disease subclassifiers that can explain this heterogeneity beyond current parameters (MSI, KRAS, BRAF). Attempts to fill...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840702/ https://www.ncbi.nlm.nih.gov/pubmed/23836465 http://dx.doi.org/10.1002/path.4212 |
_version_ | 1782478554906230784 |
---|---|
author | Budinska, Eva Popovici, Vlad Tejpar, Sabine D'Ario, Giovanni Lapique, Nicolas Sikora, Katarzyna Otylia Di Narzo, Antonio Fabio Yan, Pu Hodgson, John Graeme Weinrich, Scott Bosman, Fred Roth, Arnaud Delorenzi, Mauro |
author_facet | Budinska, Eva Popovici, Vlad Tejpar, Sabine D'Ario, Giovanni Lapique, Nicolas Sikora, Katarzyna Otylia Di Narzo, Antonio Fabio Yan, Pu Hodgson, John Graeme Weinrich, Scott Bosman, Fred Roth, Arnaud Delorenzi, Mauro |
author_sort | Budinska, Eva |
collection | PubMed |
description | The recognition that colorectal cancer (CRC) is a heterogeneous disease in terms of clinical behaviour and response to therapy translates into an urgent need for robust molecular disease subclassifiers that can explain this heterogeneity beyond current parameters (MSI, KRAS, BRAF). Attempts to fill this gap are emerging. The Cancer Genome Atlas (TGCA) reported two main CRC groups, based on the incidence and spectrum of mutated genes, and another paper reported an EMT expression signature defined subgroup. We performed a prior free analysis of CRC heterogeneity on 1113 CRC gene expression profiles and confronted our findings to established molecular determinants and clinical, histopathological and survival data. Unsupervised clustering based on gene modules allowed us to distinguish at least five different gene expression CRC subtypes, which we call surface crypt-like, lower crypt-like, CIMP-H-like, mesenchymal and mixed. A gene set enrichment analysis combined with literature search of gene module members identified distinct biological motifs in different subtypes. The subtypes, which were not derived based on outcome, nonetheless showed differences in prognosis. Known gene copy number variations and mutations in key cancer-associated genes differed between subtypes, but the subtypes provided molecular information beyond that contained in these variables. Morphological features significantly differed between subtypes. The objective existence of the subtypes and their clinical and molecular characteristics were validated in an independent set of 720 CRC expression profiles. Our subtypes provide a novel perspective on the heterogeneity of CRC. The proposed subtypes should be further explored retrospectively on existing clinical trial datasets and, when sufficiently robust, be prospectively assessed for clinical relevance in terms of prognosis and treatment response predictive capacity. Original microarray data were uploaded to the ArrayExpress database (http://www.ebi.ac.uk/arrayexpress/) under Accession Nos E-MTAB-990 and E-MTAB-1026. |
format | Online Article Text |
id | pubmed-3840702 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | John Wiley & Sons, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-38407022013-12-02 Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer Budinska, Eva Popovici, Vlad Tejpar, Sabine D'Ario, Giovanni Lapique, Nicolas Sikora, Katarzyna Otylia Di Narzo, Antonio Fabio Yan, Pu Hodgson, John Graeme Weinrich, Scott Bosman, Fred Roth, Arnaud Delorenzi, Mauro J Pathol Original Papers The recognition that colorectal cancer (CRC) is a heterogeneous disease in terms of clinical behaviour and response to therapy translates into an urgent need for robust molecular disease subclassifiers that can explain this heterogeneity beyond current parameters (MSI, KRAS, BRAF). Attempts to fill this gap are emerging. The Cancer Genome Atlas (TGCA) reported two main CRC groups, based on the incidence and spectrum of mutated genes, and another paper reported an EMT expression signature defined subgroup. We performed a prior free analysis of CRC heterogeneity on 1113 CRC gene expression profiles and confronted our findings to established molecular determinants and clinical, histopathological and survival data. Unsupervised clustering based on gene modules allowed us to distinguish at least five different gene expression CRC subtypes, which we call surface crypt-like, lower crypt-like, CIMP-H-like, mesenchymal and mixed. A gene set enrichment analysis combined with literature search of gene module members identified distinct biological motifs in different subtypes. The subtypes, which were not derived based on outcome, nonetheless showed differences in prognosis. Known gene copy number variations and mutations in key cancer-associated genes differed between subtypes, but the subtypes provided molecular information beyond that contained in these variables. Morphological features significantly differed between subtypes. The objective existence of the subtypes and their clinical and molecular characteristics were validated in an independent set of 720 CRC expression profiles. Our subtypes provide a novel perspective on the heterogeneity of CRC. The proposed subtypes should be further explored retrospectively on existing clinical trial datasets and, when sufficiently robust, be prospectively assessed for clinical relevance in terms of prognosis and treatment response predictive capacity. Original microarray data were uploaded to the ArrayExpress database (http://www.ebi.ac.uk/arrayexpress/) under Accession Nos E-MTAB-990 and E-MTAB-1026. John Wiley & Sons, Ltd 2013-09 2013-07-08 /pmc/articles/PMC3840702/ /pubmed/23836465 http://dx.doi.org/10.1002/path.4212 Text en Copyright © 2013 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. http://creativecommons.org/licenses/by/2.5/ Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation. |
spellingShingle | Original Papers Budinska, Eva Popovici, Vlad Tejpar, Sabine D'Ario, Giovanni Lapique, Nicolas Sikora, Katarzyna Otylia Di Narzo, Antonio Fabio Yan, Pu Hodgson, John Graeme Weinrich, Scott Bosman, Fred Roth, Arnaud Delorenzi, Mauro Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer |
title | Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer |
title_full | Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer |
title_fullStr | Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer |
title_full_unstemmed | Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer |
title_short | Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer |
title_sort | gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer |
topic | Original Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840702/ https://www.ncbi.nlm.nih.gov/pubmed/23836465 http://dx.doi.org/10.1002/path.4212 |
work_keys_str_mv | AT budinskaeva geneexpressionpatternsunveilanewlevelofmolecularheterogeneityincolorectalcancer AT popovicivlad geneexpressionpatternsunveilanewlevelofmolecularheterogeneityincolorectalcancer AT tejparsabine geneexpressionpatternsunveilanewlevelofmolecularheterogeneityincolorectalcancer AT dariogiovanni geneexpressionpatternsunveilanewlevelofmolecularheterogeneityincolorectalcancer AT lapiquenicolas geneexpressionpatternsunveilanewlevelofmolecularheterogeneityincolorectalcancer AT sikorakatarzynaotylia geneexpressionpatternsunveilanewlevelofmolecularheterogeneityincolorectalcancer AT dinarzoantoniofabio geneexpressionpatternsunveilanewlevelofmolecularheterogeneityincolorectalcancer AT yanpu geneexpressionpatternsunveilanewlevelofmolecularheterogeneityincolorectalcancer AT hodgsonjohngraeme geneexpressionpatternsunveilanewlevelofmolecularheterogeneityincolorectalcancer AT weinrichscott geneexpressionpatternsunveilanewlevelofmolecularheterogeneityincolorectalcancer AT bosmanfred geneexpressionpatternsunveilanewlevelofmolecularheterogeneityincolorectalcancer AT rotharnaud geneexpressionpatternsunveilanewlevelofmolecularheterogeneityincolorectalcancer AT delorenzimauro geneexpressionpatternsunveilanewlevelofmolecularheterogeneityincolorectalcancer |